Browse the corpus

Macrocephaly is a condition in which an infant's head circumference is 2 or more standard deviations above the mean for a given age, due to benign conditions or underlying causes that lead to serious sequelae such as neurological deficits and developmental delays. Measurement of head circumference, or occipital frontal circumference (OFC), is a critical component of pediatric growth monitoring and provides insight into neurodevelopment. This course reviews the clinical features and diagnostic evaluation of macrocephaly, including neuroimaging, which is utilized to distinguish acquired causes from congenital abnormalities. This activity outlines abnormal head growth, differentiation of benign macrocephaly from conditions requiring urgent intervention, and interpretation of growth trajectories within the context of genetic, metabolic, or structural etiologies. Participants will also gain an understanding of macrocephaly classification, growth patterns, diagnostic strategies, and management tailored to the underlying etiology. This activity for healthcare professionals is designed to enhance the learner's competence in identifying macrocephaly, performing the recommended evaluation, and implementing an appropriate interprofessional approach when managing this condition to improve patient outcomes and safety. Objectives: Differentiate benign familial macrocephaly from pathologic causes of macrocephaly. Interpret serial head circumference growth trajectories to determine the need for further diagnostic evaluation in patients with macrocephaly. Implement evidence-based management strategies to optimize neurologic outcomes in patients with macrocephaly. Coordinate management strategies with interprofessional team members to improve outcomes for patients with macrocephaly. Access free multiple choice questions on this topic.

Measurement of head circumference, also known as occipital frontal circumference (OFC), reflects head growth and serves as an essential tool for tracking childhood growth and neurodevelopment. On average, head circumference increases by 2 cm per month from 0 to 3 months of age and by 1 cm per month from 3 to 6 months of age. During the final 6 months of infancy, growth slows to 0.5 cm per month. Across the first year of life, head circumference increases by an average of 12 cm. After 1 year of age, head circumference increases by 1 cm every 6 months until 3 years of age and by 1 cm annually between 3 and 5 years of age, resulting in an average total gain of 5 cm from 1 to 5 years of age. Accurate head circumference measurement may prove difficult in restless infants, particularly in the presence of thick hair, requiring careful attention to proper tape placement over anatomical landmarks. Serial measurements during each health supervision visit remain necessary through 24 to 36 months of age to evaluate head growth velocity. Frequent monitoring becomes especially important in high-risk populations, including preterm infants and children with bacterial meningitis, subdural hematoma, or hydrocephalus. Any abnormal measurement warrants confirmation through repeat assessment. Macrocephaly describes a head circumference exceeding 2 standard deviations above the mean for gestational age and sex, corresponding to values above the 97th percentile.[1] Megalencephaly, often incorrectly used interchangeably with macrocephaly, specifically refers to increased growth of cerebral structures.[2] Macrocephaly represents a broader classification that includes megalencephaly as well as other causes of increased head size without cerebral overgrowth, eg, subdural fluid collections. Recognition of the diverse etiologies of macrocephaly remains essential for distinguishing benign variants from conditions requiring prompt evaluation and intervention to reduce the risk of long-term neurologic impairment and developmental delay.

Macrocephaly describes an enlarged head size without specifying an underlying cause. Before the closure of the fontanelles and sutures in children, any increase in the volume of intracranial contents leads to an increase in head size. Etiologies include increased brain parenchyma (also termed megalencephaly) or increased cerebrospinal fluid (CSF). Additional causes include increased intracranial blood volume, thickened cranial bone, or elevated intracranial pressure from other mechanisms. Megalencephaly Megalencephaly may be anatomic or metabolic. Anatomic megalencephaly involves an increase in the size or number of brain cells without an associated metabolic disease, and most often follows a familial and benign pattern. Affected patients frequently present at birth with a large head and a normal-sized body, followed by rapid head growth during the first 6 months of life, with head circumference increasing by 0.6 to 1 cm per week rather than the average 0.4 cm per week. Familial megalencephaly typically results in mild macrocephaly, measuring 2 to 4 cm above the 90th percentile, with a growth curve that remains above but parallel to the 98th percentile. Family members commonly share larger-than-average head sizes.[3] Other causes of anatomic megalencephaly vary widely and often involve genetic factors.[4] Neurocutaneous disorders, including tuberous sclerosis, neurofibromatosis, and hypomelanosis of Ito, may present with megalencephaly. Patients with autism spectrum disorder may demonstrate macrocephaly or megalencephaly, and achondroplasia may present with megalencephaly or hydrocephalus. Sotos syndrome, also referred to as cerebral gigantism, represents another cause of megalencephaly. Associated features include frontal bossing, a high forehead, a high-arched palate, intellectual disability or developmental delay, hypertelorism, and a prominent jaw or pointed chin. Most cases arise from sporadic mutations of the NSD1 gene. Metabolic megalencephaly involves enlargement of the brain parenchyma due to the accumulation of metabolic products within neural tissue. Conditions include leukodystrophies, eg, Alexander disease, lysosomal storage disorders, eg, Tay-Sachs disease, and organic acid disorders. Affected patients often present with a normal head circumference at birth followed by growth that exceeds the expected trajectory.[5] Genetic Etiologies

Metabolic megalencephaly involves enlargement of the brain parenchyma due to the accumulation of metabolic products within neural tissue. Conditions include leukodystrophies, eg, Alexander disease, lysosomal storage disorders, eg, Tay-Sachs disease, and organic acid disorders. Affected patients often present with a normal head circumference at birth followed by growth that exceeds the expected trajectory.[5] Genetic Etiologies Fragile X syndrome commonly presents with macrocephaly, intellectual disability, prominent ears and jaw, and macroorchidism, with many features becoming more apparent after puberty. The condition most frequently results from a CGG trinucleotide repeat expansion in the FMR1 gene located on the X chromosome. Nevoid basal cell carcinoma syndrome, also known as Gorlin syndrome, confers a predisposition to basal cell carcinomas and commonly presents with macrocephaly and coarse facial features. Mutations in the PTCH1 gene cause this autosomal dominant disorder. Cowden syndrome also predisposes affected individuals to certain malignancies, including thyroid and breast cancers, and may present with macrocephaly. Mutations in the PTEN gene underlie this autosomal dominant condition. Many patients with macrocephaly harbor pathogenic genetic mutations, including those in the PPP2R5D gene.[6] Genetic disorders often demonstrate variable penetrance and expressivity, resulting in a broad spectrum of clinical manifestations. Metabolic megalencephaly involves enlargement of the brain parenchyma due to the accumulation of metabolic products within neural tissue. Conditions include leukodystrophies, eg, Alexander disease, lysosomal storage disorders, eg, Tay-Sachs disease, and organic acid disorders. Affected patients often present with a normal head circumference at birth followed by growth that exceeds the expected trajectory.[5] Increased Intracranial Fluid

Metabolic megalencephaly involves enlargement of the brain parenchyma due to the accumulation of metabolic products within neural tissue. Conditions include leukodystrophies, eg, Alexander disease, lysosomal storage disorders, eg, Tay-Sachs disease, and organic acid disorders. Affected patients often present with a normal head circumference at birth followed by growth that exceeds the expected trajectory.[5] Increased Intracranial Fluid Macrocephaly may also result from increased cerebrospinal fluid (CSF) volume. In hydrocephalus, the ventricular system contains excessive CSF, leading to ventricular dilatation and elevated intracranial pressure. Mechanisms include increased CSF production, impaired absorption, or obstruction of CSF flow. Clinical manifestations of elevated intracranial pressure include lethargy, irritability, developmental delay, nausea or vomiting, and restricted upgaze. Head enlargement may occur while cranial sutures and fontanelles remain open; loss of this compensatory capacity often necessitates surgical intervention, including placement of a ventriculoperitoneal shunt. Elevated intracranial pressure may also result from space-occupying lesions within the cranial vault. Benign enlargement of the subarachnoid spaces represents another common CSF-related cause of macrocephaly, typically presenting within the first 6 months of life and occurring more frequently in boys than in girls. Neuroimaging demonstrates enlargement of the anterior subarachnoid spaces, distinguishing this entity from the symmetric anterior-to-posterior fluid collections associated with cerebral atrophy. Infants with this condition, particularly those born at term, typically show normal development and normal neurologic examination findings. Despite this, an increased risk of subdural hemorrhage exists even after minimal or absent trauma. Similar neuroimaging findings in infants with histories of complicated neonatal intensive care unit courses or early extracorporeal membrane oxygenation may represent a distinct subgroup associated with poorer neurologic and developmental outcomes.

Elevated intracranial pressure may also result from space-occupying lesions within the cranial vault. Benign enlargement of the subarachnoid spaces represents another common CSF-related cause of macrocephaly, typically presenting within the first 6 months of life and occurring more frequently in boys than in girls. Neuroimaging demonstrates enlargement of the anterior subarachnoid spaces, distinguishing this entity from the symmetric anterior-to-posterior fluid collections associated with cerebral atrophy. Infants with this condition, particularly those born at term, typically show normal development and normal neurologic examination findings. Despite this, an increased risk of subdural hemorrhage exists even after minimal or absent trauma. Similar neuroimaging findings in infants with histories of complicated neonatal intensive care unit courses or early extracorporeal membrane oxygenation may represent a distinct subgroup associated with poorer neurologic and developmental outcomes. Increased intracranial blood volume also contributes to enlarged head size and may result from hemorrhage or arteriovenous malformations. Hemorrhage may arise from nonaccidental trauma, prompting evaluation of social history and environmental factors. Physical examination findings may include additional injuries or retinal hemorrhages. Presentations involving intracranial hemorrhage related to nonaccidental trauma commonly include seizures, nausea or vomiting, lethargy, or irritability. Bone Thickening An increase in skull volume represents another cause of macrocephaly. Bone thickening may result from bone marrow expansion, as seen in thalassemia major, or from skeletal or cranial dysplasias.[7]

By definition, macrocephaly is found in about 2% to 3% of the population. Large registries have reported a prevalence at birth of 18.1 per 10,000 births.[8] Although fetal growth curves are not sex-specific, in studies, male fetuses have been found to have larger head circumferences on average than females, differing by 0.3 to 0.5 standard deviations. Therefore, differing growth patterns may potentially affect the classification of microcephaly or macrocephaly, leading to underdiagnosis or overdiagnosis depending on gender.[9][1] The specifics of epidemiology, including geographic distribution, depend on the particular underlying cause.

The pathogenesis of macrocephaly is etiology-specific, as it can result from overgrowth of the skull bones or an increase in the volume of intracranial structures, eg, CSF, blood, or brain parenchyma. Please refer to the Etiology section for more information on causes associated with macrocephaly.

Identification of macrocephaly requires the use of a standardized head measurement technique. Measurement involves wrapping a flexible tape around the head, positioning the tape just above the eyebrows anteriorly and over the most prominent portion of the occiput posteriorly. This measurement, known as the OFC, is plotted on the 2006 WHO international growth charts for children younger than 24 months, by age and sex, to determine the percentile rank. A head circumference at or above the 97th percentile meets criteria for macrocephaly.[10] Evaluation of macrocephaly requires a detailed clinical history focused on birth measurements, head growth trajectory, associated medical conditions, developmental progress, and family history of macrocephaly. Particular attention should focus on prior central nervous system trauma or infection. A history of neonatal meningitis or intraventricular hemorrhage raises concern for secondary hydrocephalus and warrants close longitudinal follow-up.[11] Physical examination, in addition to head circumference measurement and fontanelle palpation, should include assessment of overall appearance, facial features, skin findings, and a comprehensive neurologic examination to identify features suggestive of an underlying etiology or genetic syndrome. Ophthalmologic evaluation remains important, as elevated intracranial pressure may cause papilledema, although this finding may be absent in infants with open fontanelles. Additional focused examination techniques include transillumination of the calvaria, evaluation for skeletal dysplasia, and auscultation for a cranial bruit.

Clinical history, physical examination, and selective use of neuroimaging and genetic testing each contribute to the comprehensive evaluation of patients with macrocephaly.[2] When a patient demonstrates age-appropriate development, a neurologic examination with normal findings, no dysmorphic features suggestive of a genetic syndrome, and no family history of developmental or neurologic disorders, assessment with Weaver curves using parental head circumferences may guide interpretation. Findings within the normal range, when plotted on these curves, provide reassurance without the need for further diagnostic evaluation.[12] Additional assessment becomes appropriate when head circumference measurements exceed the 97th percentile on standardized growth charts. Further evaluation is also warranted when serial measurements cross 1 or more major percentile lines, indicating head growth that exceeds expected velocity, or when patients younger than 6 months experience an increase in head circumference of greater than 2 cm within 1 month. Neuroimaging plays an important role in identifying the underlying causes of macrocephaly and should follow a systematic diagnostic approach.[13] An open anterior fontanelle allows head ultrasound to serve as a simple and cost-effective initial modality for detecting intracranial abnormalities. Computed tomography offers rapid assessment but exposes infants to ionizing radiation, limiting use to situations requiring urgent information. Magnetic resonance imaging provides superior structural detail without radiation exposure, though its higher cost and the need for sedation often restrict its use.[14][15] Neuroimaging findings in benign macrocephaly commonly include dilatation of the subarachnoid spaces, with possible mild ventricular enlargement or prominence of the basilar cisterns.[16]

Management of macrocephaly depends on the underlying etiology. Presence of hydrocephalus warrants referral to neurosurgery for consideration of surgical intervention. Children with hydrocephalus accompanied by symptoms of increased ICP may require urgent neurosurgical treatment, which can prove lifesaving. Prenatal diagnosis of hydrocephalus or macrocephaly occurs in many cases.[13] Reduction of CSF volume and associated intracranial pressure may be achieved through placement of an extraventricular drain or a ventriculoperitoneal shunt. Cases without hydrocephalus may require referral to genetics, developmental pediatrics, or pediatric neurology for further evaluation and management. Macrocephalic children with epilepsy often require treatment with antiepileptic medications. Benign familial macrocephaly generally requires no intervention beyond serial head circumference monitoring and caregiver reassurance.

Evaluation of an infant with macrocephaly requires careful differentiation between isolated macrocephaly and other abnormal head shapes. Plagiocephaly describes flattening of 1 region of the skull and commonly occurs in infants with a history of prolonged head positioning in a single orientation. Craniosynostosis arises from premature fusion of cranial sutures and leads to characteristic abnormalities in skull shape. Brachycephaly results from early closure of the coronal suture and presents with a widened skull and recessed forehead. Trigonocephaly develops from the premature fusion of the metopic suture, producing a triangular-shaped forehead. Scaphocephaly occurs following early closure of the sagittal suture and presents with anterior–posterior elongation of the skull, accompanied by bitemporal narrowing. Additional congenital skull deformities may result from traumatic forces or mechanical constraints affecting the head during intrauterine development. Such forces include multiple gestation, abnormal fetal positioning, and oligohydramnios.

The prognosis for macrocephaly depends on the underlying cause. When presented with an infant with otherwise normal growth and development and a normal neurologic exam, macrocephaly, by itself, is often benign, and neurodevelopmental outcomes are good.[17][18] In these cases, enlargement of the subarachnoid space may be seen on imaging. This may still be present during long-term follow-up, but no intervention is needed.[19]

Benign familial macrocephaly is not associated with any complications. However, macrocephaly due to hydrocephalus can have serious complications, including death, if not promptly treated. Other complications associated with macrocephaly are seizures, developmental disabilities, and neurologic deficits.

Effective deterrence and patient education for macrocephaly begin with empowering caregivers to understand normal head growth patterns and the importance of routine monitoring. Caregivers should be instructed on the role of OFC measurement and the significance of serial head measurements plotted on standardized growth charts. Emphasizing proper positioning during sleep and play can help prevent positional deformities, eg, plagiocephaly, while providing reassurance when head size falls within expected familial or benign growth patterns. Education should also include awareness of warning signs that warrant prompt medical evaluation, eg, rapid head growth, developmental delays, lethargy, irritability, vomiting, or abnormal neurologic findings. Patient education also includes explaining the potential underlying causes of macrocephaly and the rationale for further evaluation when indicated. Families should understand the differences among benign familial macrocephaly, megalencephaly, hydrocephalus, and other pathologic etiologies, as well as the possible roles of neuroimaging, genetic testing, or specialty referrals. Caregivers should receive guidance on ongoing monitoring, including follow-up visits, observation for neurologic or developmental changes, and interventions when necessary, such as antiepileptic therapy, neurosurgical procedures, or referral to developmental pediatrics or genetics. Clear communication fosters informed decision-making and reduces anxiety while supporting optimal developmental and neurologic outcomes.

Macrocephaly, defined as a head circumference at or above the 97th percentile for age and sex, reflects abnormal or accelerated cranial growth and may arise from a variety of etiologies, including benign familial traits, megalencephaly, hydrocephalus, intracranial hemorrhage, or skeletal abnormalities. Accurate measurement of OFC, serial monitoring, and plotting on standardized growth charts are essential for early identification. Differentiating isolated macrocephaly from cranial deformities such as plagiocephaly or craniosynostosis and recognizing pathologic causes through history, physical examination, neuroimaging, and genetic testing supports timely diagnosis, appropriate intervention, and optimal neurodevelopmental outcomes. Effective management of macrocephaly requires coordinated interprofessional care. Physicians, advanced practitioners, and general practitioners play key roles in assessment, diagnosis, and referral for neurosurgical, genetic, or developmental evaluation. Nurses and other allied health professionals support accurate measurement, monitor growth trends, and educate families on head positioning and warning signs. Pharmacists contribute to safe medication management in cases such as epilepsy. Clear communication among team members ensures coordinated care plans, timely interventions, and patient-centered education, improving safety, developmental outcomes, and overall team performance.